Loading…

A presentation, treatment, and survival analysis of primary cardiac lymphoma cases reported from 2009 to 2019

The heart is a rare primary site of lymphoma, and cardiac involvement is thought to bring a poorer prognosis. A framework of known clinical presentations, diagnostic features, disease complications, treatments, and outcomes to improve prognostication was constructed by a systematic review in 2011. H...

Full description

Saved in:
Bibliographic Details
Published in:International journal of hematology 2020-07, Vol.112 (1), p.65-73
Main Authors: Chen, Haoguang, Qian, Shenxian, Shi, Pengfei, Liu, Lirong, Yang, Fan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c399t-542495a080fb4516633635c8aa4b9c1956ad5f718814a91df014c9a701e643cb3
cites cdi_FETCH-LOGICAL-c399t-542495a080fb4516633635c8aa4b9c1956ad5f718814a91df014c9a701e643cb3
container_end_page 73
container_issue 1
container_start_page 65
container_title International journal of hematology
container_volume 112
creator Chen, Haoguang
Qian, Shenxian
Shi, Pengfei
Liu, Lirong
Yang, Fan
description The heart is a rare primary site of lymphoma, and cardiac involvement is thought to bring a poorer prognosis. A framework of known clinical presentations, diagnostic features, disease complications, treatments, and outcomes to improve prognostication was constructed by a systematic review in 2011. However, some aspects must be discussed further in light of recent advances in lymphoma research. We collected cardiac lymphoma case reports published from January 2009 to January 2019, collected statistics from each patient, and performed a systematic analysis. The epidemiological characteristics, clinical manifestations, treatments, responses, and survival of primary cardiac lymphoma (PCL) patients are described. We obtained 158 cases of heart lymphoma, of which 101 were defined as PCL. There were more male than female cases. Most cases were diffuse large B-cell lymphoma. Six cases of PCL in cardiac myxomas were described. Patients with arrhythmia had shorter progression-free survival compared those without (HR 0.334, 95% CI 0.112–0.999, log-rank P  = 0.042). Surgery did not improve patients’ long-term prognosis or reduce the risk of death within 1 month. These data suggest that central nervous system prophylaxis is necessary. The overall survival was longer than that in data from 1949 to 2009.
doi_str_mv 10.1007/s12185-020-02881-2
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2389693543</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2389693543</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-542495a080fb4516633635c8aa4b9c1956ad5f718814a91df014c9a701e643cb3</originalsourceid><addsrcrecordid>eNp9kc9O3DAQxi1EBcvCC3BAlrj0QNoZ_0nsI1q1tBJSL-05mnUcCErirZ0g7dvwLH0yTHehUg8crJHt33yfZj7GzhE-IUD1OaFAowsQkI8xWIgDtkBT6kJWlTpkC7BCF7pCOGYnKT0AYAWqOmLHUgijZQkLNl7zTfTJjxNNXRiv-BQ9TUO-X3EaG57m-Ng9Uv_niUbqt6lLPLS5pRsobrmj2HTkeL8dNvdhoPyQfOLRb0KcfMPbGAYuACyfQq5oT9mHlvrkz_Z1yX59_fJz9a24_XHzfXV9Wzhp7VRoJZTVBAbatdJYllKWUjtDpNbWodUlNbqtMA-tyGLTAipnqQL0pZJuLZfs4053E8Pv2aepHrrkfN_T6MOcaiGNLa3USmb08j_0IcwxD5sphdKAfDFfMrGjXAwpRd_W-x3UCPVLGvUujTqnUf9NI3ss2cVeel4PvnlreV1_BuQOSPlrvPPxn_c7ss96ZJO2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2413803336</pqid></control><display><type>article</type><title>A presentation, treatment, and survival analysis of primary cardiac lymphoma cases reported from 2009 to 2019</title><source>Springer Nature</source><creator>Chen, Haoguang ; Qian, Shenxian ; Shi, Pengfei ; Liu, Lirong ; Yang, Fan</creator><creatorcontrib>Chen, Haoguang ; Qian, Shenxian ; Shi, Pengfei ; Liu, Lirong ; Yang, Fan</creatorcontrib><description>The heart is a rare primary site of lymphoma, and cardiac involvement is thought to bring a poorer prognosis. A framework of known clinical presentations, diagnostic features, disease complications, treatments, and outcomes to improve prognostication was constructed by a systematic review in 2011. However, some aspects must be discussed further in light of recent advances in lymphoma research. We collected cardiac lymphoma case reports published from January 2009 to January 2019, collected statistics from each patient, and performed a systematic analysis. The epidemiological characteristics, clinical manifestations, treatments, responses, and survival of primary cardiac lymphoma (PCL) patients are described. We obtained 158 cases of heart lymphoma, of which 101 were defined as PCL. There were more male than female cases. Most cases were diffuse large B-cell lymphoma. Six cases of PCL in cardiac myxomas were described. Patients with arrhythmia had shorter progression-free survival compared those without (HR 0.334, 95% CI 0.112–0.999, log-rank P  = 0.042). Surgery did not improve patients’ long-term prognosis or reduce the risk of death within 1 month. These data suggest that central nervous system prophylaxis is necessary. The overall survival was longer than that in data from 1949 to 2009.</description><identifier>ISSN: 0925-5710</identifier><identifier>EISSN: 1865-3774</identifier><identifier>DOI: 10.1007/s12185-020-02881-2</identifier><identifier>PMID: 32285360</identifier><language>eng</language><publisher>Singapore: Springer Singapore</publisher><subject>Arrhythmia ; B-cell lymphoma ; Case reports ; Central nervous system ; Complications ; Diagnostic systems ; Epidemiology ; Heart ; Hematology ; Lymphocytes B ; Lymphoma ; Medical prognosis ; Medical treatment ; Medicine ; Medicine &amp; Public Health ; Oncology ; Original Article ; Patients ; Prognosis ; Prophylaxis ; Statistical analysis ; Surgery ; Survival ; Survival analysis</subject><ispartof>International journal of hematology, 2020-07, Vol.112 (1), p.65-73</ispartof><rights>Japanese Society of Hematology 2020</rights><rights>Japanese Society of Hematology 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-542495a080fb4516633635c8aa4b9c1956ad5f718814a91df014c9a701e643cb3</citedby><cites>FETCH-LOGICAL-c399t-542495a080fb4516633635c8aa4b9c1956ad5f718814a91df014c9a701e643cb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32285360$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Haoguang</creatorcontrib><creatorcontrib>Qian, Shenxian</creatorcontrib><creatorcontrib>Shi, Pengfei</creatorcontrib><creatorcontrib>Liu, Lirong</creatorcontrib><creatorcontrib>Yang, Fan</creatorcontrib><title>A presentation, treatment, and survival analysis of primary cardiac lymphoma cases reported from 2009 to 2019</title><title>International journal of hematology</title><addtitle>Int J Hematol</addtitle><addtitle>Int J Hematol</addtitle><description>The heart is a rare primary site of lymphoma, and cardiac involvement is thought to bring a poorer prognosis. A framework of known clinical presentations, diagnostic features, disease complications, treatments, and outcomes to improve prognostication was constructed by a systematic review in 2011. However, some aspects must be discussed further in light of recent advances in lymphoma research. We collected cardiac lymphoma case reports published from January 2009 to January 2019, collected statistics from each patient, and performed a systematic analysis. The epidemiological characteristics, clinical manifestations, treatments, responses, and survival of primary cardiac lymphoma (PCL) patients are described. We obtained 158 cases of heart lymphoma, of which 101 were defined as PCL. There were more male than female cases. Most cases were diffuse large B-cell lymphoma. Six cases of PCL in cardiac myxomas were described. Patients with arrhythmia had shorter progression-free survival compared those without (HR 0.334, 95% CI 0.112–0.999, log-rank P  = 0.042). Surgery did not improve patients’ long-term prognosis or reduce the risk of death within 1 month. These data suggest that central nervous system prophylaxis is necessary. The overall survival was longer than that in data from 1949 to 2009.</description><subject>Arrhythmia</subject><subject>B-cell lymphoma</subject><subject>Case reports</subject><subject>Central nervous system</subject><subject>Complications</subject><subject>Diagnostic systems</subject><subject>Epidemiology</subject><subject>Heart</subject><subject>Hematology</subject><subject>Lymphocytes B</subject><subject>Lymphoma</subject><subject>Medical prognosis</subject><subject>Medical treatment</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Prophylaxis</subject><subject>Statistical analysis</subject><subject>Surgery</subject><subject>Survival</subject><subject>Survival analysis</subject><issn>0925-5710</issn><issn>1865-3774</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kc9O3DAQxi1EBcvCC3BAlrj0QNoZ_0nsI1q1tBJSL-05mnUcCErirZ0g7dvwLH0yTHehUg8crJHt33yfZj7GzhE-IUD1OaFAowsQkI8xWIgDtkBT6kJWlTpkC7BCF7pCOGYnKT0AYAWqOmLHUgijZQkLNl7zTfTJjxNNXRiv-BQ9TUO-X3EaG57m-Ng9Uv_niUbqt6lLPLS5pRsobrmj2HTkeL8dNvdhoPyQfOLRb0KcfMPbGAYuACyfQq5oT9mHlvrkz_Z1yX59_fJz9a24_XHzfXV9Wzhp7VRoJZTVBAbatdJYllKWUjtDpNbWodUlNbqtMA-tyGLTAipnqQL0pZJuLZfs4053E8Pv2aepHrrkfN_T6MOcaiGNLa3USmb08j_0IcwxD5sphdKAfDFfMrGjXAwpRd_W-x3UCPVLGvUujTqnUf9NI3ss2cVeel4PvnlreV1_BuQOSPlrvPPxn_c7ss96ZJO2</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Chen, Haoguang</creator><creator>Qian, Shenxian</creator><creator>Shi, Pengfei</creator><creator>Liu, Lirong</creator><creator>Yang, Fan</creator><general>Springer Singapore</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20200701</creationdate><title>A presentation, treatment, and survival analysis of primary cardiac lymphoma cases reported from 2009 to 2019</title><author>Chen, Haoguang ; Qian, Shenxian ; Shi, Pengfei ; Liu, Lirong ; Yang, Fan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-542495a080fb4516633635c8aa4b9c1956ad5f718814a91df014c9a701e643cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Arrhythmia</topic><topic>B-cell lymphoma</topic><topic>Case reports</topic><topic>Central nervous system</topic><topic>Complications</topic><topic>Diagnostic systems</topic><topic>Epidemiology</topic><topic>Heart</topic><topic>Hematology</topic><topic>Lymphocytes B</topic><topic>Lymphoma</topic><topic>Medical prognosis</topic><topic>Medical treatment</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Prophylaxis</topic><topic>Statistical analysis</topic><topic>Surgery</topic><topic>Survival</topic><topic>Survival analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Haoguang</creatorcontrib><creatorcontrib>Qian, Shenxian</creatorcontrib><creatorcontrib>Shi, Pengfei</creatorcontrib><creatorcontrib>Liu, Lirong</creatorcontrib><creatorcontrib>Yang, Fan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Haoguang</au><au>Qian, Shenxian</au><au>Shi, Pengfei</au><au>Liu, Lirong</au><au>Yang, Fan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A presentation, treatment, and survival analysis of primary cardiac lymphoma cases reported from 2009 to 2019</atitle><jtitle>International journal of hematology</jtitle><stitle>Int J Hematol</stitle><addtitle>Int J Hematol</addtitle><date>2020-07-01</date><risdate>2020</risdate><volume>112</volume><issue>1</issue><spage>65</spage><epage>73</epage><pages>65-73</pages><issn>0925-5710</issn><eissn>1865-3774</eissn><abstract>The heart is a rare primary site of lymphoma, and cardiac involvement is thought to bring a poorer prognosis. A framework of known clinical presentations, diagnostic features, disease complications, treatments, and outcomes to improve prognostication was constructed by a systematic review in 2011. However, some aspects must be discussed further in light of recent advances in lymphoma research. We collected cardiac lymphoma case reports published from January 2009 to January 2019, collected statistics from each patient, and performed a systematic analysis. The epidemiological characteristics, clinical manifestations, treatments, responses, and survival of primary cardiac lymphoma (PCL) patients are described. We obtained 158 cases of heart lymphoma, of which 101 were defined as PCL. There were more male than female cases. Most cases were diffuse large B-cell lymphoma. Six cases of PCL in cardiac myxomas were described. Patients with arrhythmia had shorter progression-free survival compared those without (HR 0.334, 95% CI 0.112–0.999, log-rank P  = 0.042). Surgery did not improve patients’ long-term prognosis or reduce the risk of death within 1 month. These data suggest that central nervous system prophylaxis is necessary. The overall survival was longer than that in data from 1949 to 2009.</abstract><cop>Singapore</cop><pub>Springer Singapore</pub><pmid>32285360</pmid><doi>10.1007/s12185-020-02881-2</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0925-5710
ispartof International journal of hematology, 2020-07, Vol.112 (1), p.65-73
issn 0925-5710
1865-3774
language eng
recordid cdi_proquest_miscellaneous_2389693543
source Springer Nature
subjects Arrhythmia
B-cell lymphoma
Case reports
Central nervous system
Complications
Diagnostic systems
Epidemiology
Heart
Hematology
Lymphocytes B
Lymphoma
Medical prognosis
Medical treatment
Medicine
Medicine & Public Health
Oncology
Original Article
Patients
Prognosis
Prophylaxis
Statistical analysis
Surgery
Survival
Survival analysis
title A presentation, treatment, and survival analysis of primary cardiac lymphoma cases reported from 2009 to 2019
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T07%3A37%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20presentation,%20treatment,%20and%20survival%C2%A0analysis%20of%20primary%20cardiac%20lymphoma%20cases%20reported%20from%202009%20to%202019&rft.jtitle=International%20journal%20of%20hematology&rft.au=Chen,%20Haoguang&rft.date=2020-07-01&rft.volume=112&rft.issue=1&rft.spage=65&rft.epage=73&rft.pages=65-73&rft.issn=0925-5710&rft.eissn=1865-3774&rft_id=info:doi/10.1007/s12185-020-02881-2&rft_dat=%3Cproquest_cross%3E2389693543%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c399t-542495a080fb4516633635c8aa4b9c1956ad5f718814a91df014c9a701e643cb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2413803336&rft_id=info:pmid/32285360&rfr_iscdi=true